Stan Rose
Stan Rose (born February 2, 1956) is an American biologist, biotechnology executive, and entrepreneur. He works to commercialize inventions related to genome analysis.
Early life and education[edit]
Born in the Bronx, New York, and raised in Greenburgh, New York. Rose earned his B.A. from Cornell University in 1978 and his Ph.D. from the Massachusetts Institute of Technology in 1985.[1]
Career[edit]
Rose was director of the PCR business for Perkin-Elmer and Applied Biosystems during the early 1990s.[2] He co-founded Genetic MicroSystems in 1997,[3] a microarray instrumentation company that was acquired by Affymetrix in 2000.[4] Between 2003 and 2007, Rose was CEO of NimbleGen Systems, Inc.,[5] a genomics tool company that was acquired by Roche in 2007.[6] [7]
Rose was a director of Cellular Dynamics International (CDI), which developed pluripotent stem cell technology for drug discovery and cell therapy.[8] CDI completed an IPO in 2013,[9] and was acquired by FujiFilm in 2015.[10]
Rose was co-founder and CEO of Transplant Genomics Inc. (TGI), a molecular diagnostics company commercializing tests to help physicians assess adequacy of immunosuppression for organ transplant recipients.[11] [12] TGI was acquired by Eurofins Scientific SE (ERF.PA) in 2019.[13]
Since 2008, he has served as president of Rose Ventures, an advisory and investment firm that works with early stage companies.[14] [15]
Rose is a Senior Fellow with the Council on Strategic Risks, participating in the Alliance to End Biological Threats.[16]
References[edit]
- ↑ Rose, Stanley (1985). "Regulation of pituitary function by 1α,25-dihydroxyvitamin D₃". PHD Thesis.
- ↑ Gershon, Diane (1993). "Discounts offered for large-scale users of Taq". Nature. 364: 374. doi:10.1038/364374b0.
- ↑ Bushnell, Davis (April 19, 1998). "Taking fast track to genetic analysis". The Boston Globe.
- ↑ "Affymetrix Acquires Genetic MicroSystems". Bioprocess Onilne. September 14, 1999.
- ↑ "Roche NimbleGen CEO Stan Rose to speak on exit strategies for start-up companies". news.wisc.edu.
- ↑ "Roche Acquires Nimblegen to Gain Entry into High-Growth Research Microarrray Market". Technology Networks.
- ↑ "Roche agrees to buy NimbleGen for $272.5 mln". Reuters. 2007-06-19. Retrieved 2023-07-29.
- ↑ [: https://www.sec.gov/Archives/edgar/data/1482080/000148208013000014/cdi-sx1publicfiling12013.htm#s9E155D96DEB0ACBBA144B41EB83827DD]
- ↑ [https://www.ibmadison.com/cellular-dynamics-raises-46-million-in-ipo-sees-stock-price-drop-20/
- ↑ "Fujifilm to acquire Cellular Dynamics for $307 million". www.jsonline.com.
- ↑ Keshavan, Meghana (July 14, 2014). "New test from Transplant Genomics will spot organ rejection as soon as it starts".
- ↑ [1]
- ↑ "Eurofins Acquires Transplant Genomics". GenomeWeb. June 25, 2019.
- ↑ "Rose Ventures Inc". Rose Ventures Inc.
- ↑ "Rose Ventures Investor Profile: Portfolio & Exits | PitchBook".
- ↑ "Council on Strategic Risks". 19 December 2019.
This article "Stan Rose" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Stan Rose. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
